التفاصيل البيبلوغرافية
| العنوان: |
European e-Delphi process to define expert consensus on electrochemotherapy treatment indications, procedural aspects, and quality indicators in melanoma. |
| المؤلفون: |
Campana, Luca G., Farronato, Sofia, Hodgetts, Jackie, Odili, Joy, Vecchiato, Antonella, Bracken, Alison, Baier, Susanne, Bechara, Falk G., Borgognoni, Lorenzo, Caracò, Corrado, Carvalhal, Sara, Covarelli, Piero, Clover, James, Eisendle, Klaus, Fantini, Fabrizio, Teresa Fierro, Maria, Farricha, Victor, Gregorelli, Chiara, Hafner, Jürg, Kunte, Christian |
| المصدر: |
British Journal of Surgery; Jul2023, Vol. 110 Issue 7, p818-830, 13p |
| مصطلحات موضوعية: |
MELANOMA, DELPHI method, LIKERT scale, QUALITY assurance, DERMATOLOGISTS, COMORBIDITY, MEDICAL audit |
| مستخلص: |
Background: Skin metastases are an important co-morbidity in melanoma. Despite broad adoption, electrochemotherapy implementation is hindered by a lack of treatment indications, uncertainty regarding procedural aspects, and the absence of quality indicators. An expert consensus may harmonize the approach among centres and facilitate comparison with other therapies. Methods: An interdisciplinary panel was recruited for a three-round e-Delphi survey. A literature-based 113-item questionnaire was proposed to 160 professionals from 53 European centres. Participants rated each item for relevance and degree of agreement on a fivepoint Likert scale, and received anonymous controlled feedback to allow revision. The items that reached concordant agreement in two successive iterations were included in the final consensus list. In the third round, quality indicator benchmarks were defined using a real-time Delphi method. Results: The initial working group included 122 respondents, of whom 100 (82 per cent) completed the first round, thus qualifying for inclusion in the expert panel (49 surgeons, 29 dermatologists, 15 medical oncologists, three radiotherapists, two nurse specialists, two clinician scientists). The completion rate was 97 per cent (97 of 100) and 93 per cent (90 of 97) in the second and third rounds respectively. The final consensus list included 54 statements with benchmarks (treatment indications, (37); procedural aspects, (1); quality indicators, (16)). Conclusion: An expert panel achieved consensus on the use of electrochemotherapy in melanoma, with a core set of statements providing general direction to electrochemotherapy users to refine indications, align clinical practices, and promote quality assurance programmes and local audits. The residual controversial topics set future research priorities to improve patient care. [ABSTRACT FROM AUTHOR] |
|
Copyright of British Journal of Surgery is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
